Fertility and sterility · 2008
Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
You Joyce H S, Sahota Daljit Singh, Yuen Pong Mo
Аннотация
OBJECTIVE: To compare the cost and quality-adjusted life-years (QALYs) of hysterectomy, myomectomy, and uterine artery embolization (UAE) for symptomatic control of uterine fibroids.
DESIGN: A cost-utility analysis conducted by using Markov modeling.
SETTING: The analysis was conducted from the perspective of Hong Kong society.
PATIENT(S): A hypothetical cohort of patients presenting with symptomatic uterine fibroids.
INTERVENTION(S): Hysterectomy, myomectomy, or UAE.
MAIN OUTCOME MEASURE(S): Health-care resource use and QALYs over 5 years.
RESULT(S): The base-case analysis showed that hysterectomy was the most effective treatment (4.368 QALYs), followed by myomectomy (4.273 QALYs) and UAE (4.245 QALYs) over 5 years. Hysterectomy was less costly (USD8418) (1USD = 7.8HKD) than UAE (USD8847) and myomectomy (USD9036). Monte Carlo 10,000 simulations showed that the hysterectomy group was less costly than the UAE and myomectomy groups 84.1% and 79.1% of the time, and it also gained higher number of QALYs than the UAE and myomectomy groups over 97% of the time.
CONCLUSION(S): Hysterectomy appears to be more cost-effective than myomectomy and UAE for management of symptomatic uterine fibroids over a 5-year period among patients who do not have a preference for uterus-conserving interventions.
DESIGN: A cost-utility analysis conducted by using Markov modeling.
SETTING: The analysis was conducted from the perspective of Hong Kong society.
PATIENT(S): A hypothetical cohort of patients presenting with symptomatic uterine fibroids.
INTERVENTION(S): Hysterectomy, myomectomy, or UAE.
MAIN OUTCOME MEASURE(S): Health-care resource use and QALYs over 5 years.
RESULT(S): The base-case analysis showed that hysterectomy was the most effective treatment (4.368 QALYs), followed by myomectomy (4.273 QALYs) and UAE (4.245 QALYs) over 5 years. Hysterectomy was less costly (USD8418) (1USD = 7.8HKD) than UAE (USD8847) and myomectomy (USD9036). Monte Carlo 10,000 simulations showed that the hysterectomy group was less costly than the UAE and myomectomy groups 84.1% and 79.1% of the time, and it also gained higher number of QALYs than the UAE and myomectomy groups over 97% of the time.
CONCLUSION(S): Hysterectomy appears to be more cost-effective than myomectomy and UAE for management of symptomatic uterine fibroids over a 5-year period among patients who do not have a preference for uterus-conserving interventions.
Предметные рубрики MeSH
Computer SimulationCost-Benefit AnalysisFemaleHealth Care CostsHong KongHumansHysterectomyLeiomyomaMarkov ChainsModels, EconomicMyometriumPostoperative ComplicationsQuality-Adjusted Life YearsReoperationReproducibility of ResultsTime FactorsTreatment OutcomeUterine Artery EmbolizationUterine Neoplasms